T1	intervention 27 44	follow-up program
T2	total-participants 480 506	One hundred and twenty-one
T3	control 535 562	standard clinical follow-up
T4	control-participants 566 568	63
T5	intervention-participants 602 604	58
T6	eligibility 48 75	patients with breast cancer
T8	outcome 953 961	relapses
T9	cv-bin-abs 963 965	11
T10	iv-bin-abs 1002 1004	13
T11	outcome 1043 1068	overall cost of follow-up
T12	cv-cont-mean 1073 1085	24,567 euros
T13	iv-cont-mean 1131 1143	74,171 euros
